Last reviewed · How we verify
NCT03308279
Prediction Model for Minimizing the Risk of Median Nerve Puncture
trial testing Ultrasound in Pronator Teres Nerve Syndrome in 65 participants. Completed in 15 August 2017.
30 June 2017
Quick facts
| Lead sponsor | Universidad Autonoma de Madrid |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 65 |
| Start date | 1 September 2016 |
| Primary completion | 30 June 2017 |
| Estimated completion | 15 August 2017 |
Drugs / interventions tested
- Ultrasound
Conditions studied
- Pronator Teres Nerve Syndrome — all drugs for Pronator Teres Nerve Syndrome →
Sponsor
Universidad Autonoma de Madrid — full company profile →
Who can join
Adults 18 to 65, any sex, with Pronator Teres Nerve Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of this study was to correlate anthropometric measures of the forearm in healthy subjects with the ultrasound pronator teres depth to determine the needle length in order to avoid injury of the median nerve during pronator teres dry needle approach. A cross-sectional study, was carried out in order to perform a predictive model for the median nerve depth into the pronator teres muscle using a decision tree analysis algorithm.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prediction Model for Choosing Needle Length to Minimize Risk of Median Nerve Puncture With Dry Needling of the Pronator Teres.
Ferrer-Peña R, Calvo-Lobo C, Gómez M, Muñoz-García D. · · 2019 · cited 5× · PMID 31262581 · DOI 10.1016/j.jmpt.2018.11.020
Verify or expand the search:
- PubMed search for NCT03308279
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasound
Trials testing the same drug.
- NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
- NCT07505433 — Ultrasound Monitoring of Bone Healing in Ilizarov Bone Transport · not yet recruiting
- NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
- NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
- NCT07169890 — Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris · NA · completed
Other Universidad Autonoma de Madrid trials
Trials by the same sponsor.
- NCT07090434 — Effect of Bei App for Fibromyalgia · NA · not yet recruiting
- NCT06726447 — Artificial Intelligence Satisfaction in Professionals and Patients · NA · recruiting
- NCT06601478 — Development and Implementation of a Tool for the Evaluation and Monitoring of the Mediterranean Lifestyle in the Clinica · NA · recruiting
- NCT05623579 — Education on BDNF on Pain Levels · NA · unknown
- NCT05736172 — 3h of PNE on BDNF and Pain Levels · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03308279 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Madrid
- Last refreshed: 13 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03308279.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing